Astragaloside IV and Cycloastragenol Stimulate the Phosphorylation of Extracellular Signal-Regulated Protein Kinase in Multiple Cell Types

Abstract

Two Chinese herb-derived small molecule telomerase activators, astragaloside IV (AG-IV) and cycloastragenol (CAG), have recently been shown to improve the proliferative response of CD8⁺ T lymphocytes from HIV-infected patients by upregulating telomerase activity. Here, we examined the signaling mechanism of AG-IV and CAG. Telomerase activity in human embryonic kidney HEK293 fibroblasts was increased upon treatment with increasing concentrations of AG-IV or CAG. Both compounds induced the phosphorylation of extracellular signal-regulated protein kinase (ERK) in a time- and dose-dependent manner in HEK293 cells and HEK-neo keratinocytes. AG-IV and CAG also stimulated ERK phosphorylation in other cell lines of lung, brain, mammary, endothelial, and hematopoietic origins. Use of selective inhibitors and dominant negative mutants revealed the involvement of c-Src, MEK (ERK kinase), and epidermal growth factor receptor in CAG-induced ERK phosphorylation. Our data indicate that AG-IV and CAG may exert their cellular effects through the activation of the Src/MEK/ERK pathway.

Key words

Astragalus membranaceus - Fabaceae - cycloartane triterpenoid saponin - mitogen-activated protein kinase - telomerase activation

References

• 1 Bensky D, Gamble A, Kaptchuk T J. Chinese herbal medicine: materia medica. Revised edition. Seattle: Eastland Press; 1993: 581
• 2 Chen G, Huang W. Progress in pharmacological effects of compositions of Astragalus membranaceus.  Chin J New Drugs. 2008;  17 1482-1485
• 3 Ma X Q, Shi Q, Duan J A, Dong T T, Tsim K W. Chemical analysis of Radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations.  J Agric Food Chem. 2002;  50 4861-4866
• 4 Li Z, Cao Q. Effects of astragaloside IV on myocardial calcium transport and cardiac function in ischemic rats.  Acta Pharmacol Sin. 2002;  23 898-904
• 5 Zhang W, Chen H, Zhang C, Liu R, Li H, Chen H. Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro.  Planta Med. 2006;  72 4-8
• 6 Luo Y, Qin Z, Hong Z, Zhang X, Ding D, Fu J, Zhang W, Chen J. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia.  Neurosci Lett. 2004;  363 218-223
• 7 Yu Q, Zhu T, Zhang Y. Effect of astrgaloside IV on the long-term consequences of renal ischemia-reperfusion injury in rat.  Zhonghua Yi Xue Za Zhi. 2004;  84 1412-1415
• 8 Xu X, Chen X, Ji H, Li P, Bian Y, Yang D, Xu J, Bian Z, Zhang J. Astragaloside IV improved intracellular calcium handling in hypoxia-reoxygenated cardiomyocytes via the sarcoplasmic reticulum Ca-ATPase.  Pharmacology. 2008;  81 325-332
• 9 Zhang W, Hufnagl P, Binder B, Wojta J. Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-κB activation and adhesion molecule expression.  Thromb Haemost. 2003;  90 904-914
• 10 Zhang Y, Zhu H, Huang C, Cui X, Gao Y, Huang Y, Gong W, Zhao Y, Guo S. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma.  J Cardiovasc Pharmacol. 2006;  47 190-195
• 11 Wang Y, Li X, Song C, Hu Z. Effect of astragaloside IV on T, B lymphocyte proliferation and peritoneal macrophage function in mice.  Acta Pharmacol Sin. 2002;  23 263-266
• 12 Xu H, You C, Zhang R, Gao P, Wang Z. Effects of Astragalus polysaccharides and astragalosides on the phagocytosis of Mycobacterium tuberculosis by macrophages.  J Int Med Res. 2007;  35 84-90
• 13 Fauce S R, Jamieson B D, Chin A C, Mitsuyasu R T, Parish S T, Ng H L, Kitchen C M, Yang O O, Harley C B, Effros R B. Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes.  J Immunol. 2008;  181 7400-7406
• 14 Bosc D G, Goueli B S, Janknecht R. HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1.  Oncogene. 2001;  20 6215-6224
• 15 Breitschopf K, Zeiher A M, Dimmeler S. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism.  FEBS Lett. 2001;  493 21-25
• 16 Maida Y, Kyo S, Kanaya T, Wang Z, Yatabe N, Tanaka M, Nakamura M, Ohmichi M, Gotoh N, Murakami S, Inoue M. Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway.  Oncogene. 2002;  21 4071-4079
• 17 Kam A Y, Liu A M, Wong Y H. Formyl peptide-receptor like-1 requires lipid raft and extracellular signal-regulated protein kinase to activate inhibitor-κB kinase in human U87 astrocytoma cells.  J Neurochem. 2007;  103 1553-1566
• 18 Liu A M, Lo R K, Wong C S, Morris C, Wise H, Wong Y H. Activation of STAT3 by Gα_s distinctively requires protein kinase A, JNK, and phosphatidylinositol 3-kinase.  J Biol Chem. 2006;  281 35812-35825
• 19 New D C, Wu K, Kwok A W, Wong Y H. G protein-coupled receptor-induced Akt activity in cellular proliferation and apoptosis.  FEBS J. 2007;  274 6025-6036
• 20 Zakian V A. Structure and function of telomeres.  Annu Rev Genet. 1989;  23 579-604
• 21 Goueli B S, Janknecht R. Upregulation of the catalytic telomerase subunit by the transcription factor ER81 and oncogenic HER2/Neu, Ras, or Raf.  Mol Cell Biol. 2004;  24 25-35
• 22 Wang Z, Kyo S, Takakura M, Tanaka M, Yatabe N, Maida Y, Fujiwara M, Hayakawa J, Ohmichi M, Koike K, Inoue M. Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway.  Cancer Res. 2000;  60 5376-5381
• 23 Li H, Pinto A R, Duan W, Li J, Toh B H, Liu J P. Telomerase down-regulation does not mediate PC12 pheochromocytoma cell differentiation induced by NGF, but requires MAP kinase signalling.  J Neurochem. 2005;  95 891-901
• 24 Liu A M, Wong Y H. Activation of nuclear factor κB by somatostatin type 2 receptor in pancreatic acinar AR42J cells involves Gα₁₄ and multiple signaling components: a mechanism requiring protein kinase C, calmodulin-dependent kinase II, ERK, and c-Src.  J Biol Chem. 2005;  280 34617-34625
• 25 Tsu R C, Chan J S, Wong Y H. Regulation of multiple effectors by the cloned δ-opioid receptor: stimulation of phospholipase C and type II adenylyl cyclase.  J Neurochem. 1995;  64 2700-2707
• 26 Zhu J, Lee S, Ho M K, Hu Y, Pang H, Ip F C, Chin A C, Harley C B, Ip N Y, Wong Y H. In vitro intestinal absorption and first-pass intestinal and hepatic metabolism of cycloastragenol, a potent small molecule telomerase activator.  Drug Metab Pharmacokinet. 2010;  25 477-486
• 27 Zhu F, Li W, Yin Y, Li W. Effect of astragalosides on activation of extracellular signal regulated kinase in hippocampal neuron after injury induced by hypoxia/reoxygenation.  Acta Univ Med Anhui. 2009;  44 471-474
• 28 Nguyen T T, Scimeca J C, Filloux C, Peraldi P, Carpentier J L, Van Obberghen E. Co-regulation of the mitogen-activated protein kinase, extracellular signal-regulated kinase 1, and the 90-kDa ribosomal S6 kinase in PC12 cells. Distinct effects of the neurotrophic factor, nerve growth factor, and the mitogenic factor, epidermal growth factor.  J Biol Chem. 1993;  268 9803-9810
• 29 Lowes V L, Ip N Y, Wong Y H. Integration of signals from receptor tyrosine kinases and G protein-coupled receptors.  Neurosignals. 2002;  11 5-19
• 30 Traverse S, Seedorf K, Paterson H, Marshall C J, Cohen P, Ullrich A. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor.  Curr Biol. 1994;  4 694-701
• 31 Ramos J W. The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells.  Int J Biochem Cell Biol. 2008;  40 2707-2719
• 32 Werry T D, Christopoulos A, Sexton P M. Mechanisms of ERK1/2 regulation by seven-transmembrane-domain receptors.  Curr Pharm Des. 2006;  12 1683-1702
• 33 Illario M, Cavallo A L, Bayer K U, Di Matola T, Fenzi G, Rossi G, Vitale M. Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation.  J Biol Chem. 2003;  278 45101-45108
• 34 Choe E S, Wang J Q. Group I metabotropic glutamate receptors control phosphorylation of CREB, Elk-1 and ERK via a CaMKII-dependent pathway in rat striatum.  Neurosci Lett. 2001;  313 129-132
• 35 Qiu L, Wang Q, Di W, Jiang Q, Schefeller E, Derby S, Wanebo H, Yan B, Wan Y. Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid.  Int J Oncol. 2005;  27 823-830
• 36 Poeckel D, Tausch L, Altmann A, Feisst C, Klinkhardt U, Graff J, Harder S, Werz O. Induction of central signalling pathways and select functional effects in human platelets by beta-boswellic acid.  Br J Pharmacol. 2005;  146 514-524
• 37 Biscardi J S, Maa M C, Tice D A, Cox M E, Leu T H, Parsons S J. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr⁸⁴⁵ and Tyr¹¹⁰¹ is associated with modulation of receptor function.  J Biol Chem. 1999;  274 8335-8343
• 38 Yarden Y. The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities.  Eur J Cancer. 2001;  37 S3-S8
• 39 Xu D, Dwyer J, Li H, Duan W, Liu J P. Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc.  J Biol Chem. 2008;  283 23567-23580